CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Boothwyn Pharmacy LLC recalls Semaglutide and 1 more

Read the official FDA notice

Published
10 Sept 2025
Units affected
4 products
Agency
FDA
Country
United States

The hazard

Subpotent Drug

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496

Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Brand / company
Boothwyn Pharmacy LLC
Codes / lots
03202025@9 BUD 07/18/2025 | 06092025@23 BUD 09/09/2025 | 03202025@5, 03202025@6, 03202025@7, 03202025@8 BUD 07/18/2025 | 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.